Across TCGA cell cohorts, CCDC151 mutation is significantly associated with the drug of many other genes, with 12 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible CCDC151-associated genes across cancer lineages are Sabutoclax, WYE-125132, and CZC24832. Each is linked with CCDC151 in more than 1 cancer types. Because this analysis shows association rather than direction, both CCDC151-to-partner and partner-to-CCDC151 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CCDC151→partner) and Y-score (partner→CCDC151) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LARGE_INTESTINE	Sabutoclax →	+0.506	+2.769	.016	.040	3	1
LARGE_INTESTINE	WYE-125132 →	+0.618	+2.652	.014	.045	2	1
LARGE_INTESTINE	CZC24832 →	+0.290	+2.646	.025	.047	1	1
LARGE_INTESTINE	GSK2606414 →	+0.495	+2.769	.010	.040	1	1
LARGE_INTESTINE	GSK2110183B →	+0.758	+2.649	.011	.046	1	1
LARGE_INTESTINE	LMB_AB1 →	+0.304	+2.649	.042	.046	1	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 12 associations by consensus.

Exploration

CCDC151 survival (RNA) · tumor vs normal (RNA) · all CCDC151 data types